Articles

Imatinib and spironolactone suppress hepcidin expression

Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg and Molecular Medicine Partnership Unit, Heidelberg, Germany;International Institute of Molecular and Cell Biology, Warsaw, Poland
Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg and Molecular Medicine Partnership Unit, Heidelberg, Germany
Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg and Molecular Medicine Partnership Unit, Heidelberg, Germany
Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg and Molecular Medicine Partnership Unit, Heidelberg, Germany
Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg and Molecular Medicine Partnership Unit, Heidelberg, Germany
Department of Hepatobiliary Surgery and Visceral Transplantation, University of Berlin, Germany;Department of Hepatobiliary Surgery and Visceral Transplantation, University of Leipzig, Germany
Department of Hepatobiliary Surgery and Visceral Transplantation, University of Berlin, Germany;Department of Hepatobiliary Surgery and Visceral Transplantation, University of Leipzig, Germany
Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg and Molecular Medicine Partnership Unit, Heidelberg, Germany
Vol. 102 No. 7 (2017): July, 2017 https://doi.org/10.3324/haematol.2016.162917